Organon (OGN) Restructuring Costs (2020 - 2026)
Organon (OGN) posted quarterly Restructuring Costs of $31.0 million for Q1 2026, down 63.95% year-over-year from $86.0 million in Q1 2025, and up 342.86% on a QoQ basis from $7.0 million in Q4 2025.
Organon (OGN) Restructuring Costs (2020 - 2026) Analysis & Trends
Organon (OGN) has reported Restructuring Costs for 7 consecutive years, with $31.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Restructuring Costs fell 63.95% year-over-year to $31.0 million; the TTM figure through Mar 2026 stood at $40.0 million (down 57.45% YoY), while the FY2025 annual figure was $95.0 million, up 206.45% from the prior year.
- Restructuring Costs came in at $31.0 million for Q1 2026 at Organon, up from $7.0 million in the prior quarter.
- The five-year high for Restructuring Costs was $86.0 million in Q1 2025, with the low at $2.0 million in Q2 2025.
- Average Restructuring Costs over 5 years is $24.9 million, with a median of $14.0 million recorded in 2022.
- Across the five-year window, Restructuring Costs jumped 1000.0% in 2022 and slumped 86.67% in 2024, its largest moves.
- Year by year, Restructuring Costs stood at $17.0 million in 2022, then jumped by 252.94% to $60.0 million in 2023, then plunged by 86.67% to $8.0 million in 2024, then declined by 12.5% to $7.0 million in 2025, then jumped by 342.86% to $31.0 million in 2026.
- According to Business Quant data, Restructuring Costs over the past three periods registered $31.0 million, $7.0 million, and $2.0 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Organon | 3.53 Bn | 2.41 Bn | 783.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 86.00 Mn |
| Dec 31, 2024 | 8.00 Mn |
| Mar 31, 2024 | 23.00 Mn |
| Dec 31, 2023 | 60.00 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 17.00 Mn |
| Sep 30, 2022 | 11.00 Mn |
| Sep 30, 2021 | 1.00 Mn |
| Jun 30, 2021 | 1.00 Mn |
| Mar 31, 2021 | 1.00 Mn |
| Dec 31, 2020 | 17.00 Mn |
| Sep 30, 2020 | 12.00 Mn |
| Jun 30, 2020 | 19.00 Mn |
| Mar 31, 2020 | 12.00 Mn |